Theriva Biologics, Inc. (TOVX)

Key Insights

• The company was unable to convene its Special Meeting of Stockholders due to a lack of quorum, delaying the approval process for the warrant exercise proposal.
• Under the warrant inducement agreement, the company is required to continue calling additional stockholder meetings every 60 days to seek approval until the earlier of obtaining approval or the warrants expiring.
• The company's inability to convene the Special Meeting and the ongoing requirement to hold additional meetings could create uncertainty and delays in the company's capital raising efforts.